Variable | Patients | P value | |||
---|---|---|---|---|---|
Chest CT score subgroup | |||||
0–100(group 1) | 101–200(group 2) | >200(group 3) | |||
N | 108 | 50 | 23 | 11 | |
Blood cells | |||||
 WBCs× 109/L, normal range: 3.5–9.5 | 5.7(4.5,7.8) | 5.9(4.4,7.8) △ | 5.5(4.6,6.1) △ | 5.4(4.4,9.5) *§ | 0.001 |
 Increased | 10 (9.3%) | 6(12%) | 0(0%) | 2(18%) | / |
 Decreased | 10(9.3%) | 5(10%) | 2(9%) | 1(9%) | / |
 Neutrophils×109/L, normal range: 1.8–6.3 | 4.1(2.9,5.9) | 4.4(2.7,6.1) △ | 3.5(3.1,4.3) △ | 3.8(2.9,7.4) *§ | < 0.001 |
 LYs × 109/L, normal range: 1.1–3.2 | 1.1(0.75,1.55) | 1.1(0.77,1.51) §△ | 1.15(0.67,1.73) * | 0.83(0.74,1.27) * | < 0.001 |
 Decreased | 56(52%) | 26(52%) | 11(48%) | 7(64%) | / |
 Platelets ×109/L, normal range: 125–350 | 266(174,340) | 265(156,338) | 268(160,363) | 261(211,342) | 0.251 |
 Haemoglobin, g/L, normal range: 115–150 | 129(114,143) | 130(111,144) | 129(117,136) | 127(114,147) | 0.410 |
Coagulation parameters | |||||
 Activated partial thromboplastin time, s, normal range: 29–42 | 38.3(35.8,41.2) | 38.2(35.7,40.7) | 38.5(36.1,41.9) | 41.3(36.1,44) | 0.909 |
 Prothrombin time, s, normal range: 11.5–14.5 | 13.8 (13.3,14.3) | 13.9(13.6,14.5) | 13.7(13.2,14.6) | 13.6(13,14.3) | 0.076 |
 D-dimer, μg/mL, normal range: < 0.5 | 0.71 (0.40,1.58) | 0.64(0.31,1.67) &△ | 0.58(0.42,1.2) ▼ | 0.84(0.46,1.83) * | < 0.001 |
 Increased | 62(57%) | 20(40%) | 11(48%) | 5(46%) | / |
Blood biochemistry | |||||
 Albumin, g/L, normal range: 35–52 | 35.3(32,39.4) | 36.3(31.8,40) | 37.2(32.4,40.2) | 33.3(31,37.7) | 0.183 |
 Alanine aminotransferase, U/L, normal range: ≤33 | 27(17,43) | 29(16.8,45) | 31(18,48) | 21(15,32) | 0.426 |
 Aspartate aminotransferase, U/L, normal range: ≤32 | 25 (21,39) | 24(21,37) | 32(23,47) | 25(19,38) | 0.778 |
 Total bilirubin, mmol/L, normal range: ≤21 | 9.5(7.2,13) | 8.9(6.9,12.1) | 11.6(7.9,15.1) | 9.8(7.1.,13.4) | 0.068 |
 Blood urea nitrogen, mmol/L, normal range: 1.7–8.3 | 4.8(3.6,6.1) | 5(3.6,6) &∫ | 4.7(3.7,5.3) ▼ | 4.7(3.6,7) ▼ | 0.022 |
 Serum creatinine, μmol/L, normal range: 45–84 | 71(57,86) | 70(57,86) | 81(67,87) | 68(55,78) | 0.538 |
 Increased | 30 (28%) | 14(28%) | 10(44%) | 1(9%) | / |
 CK–MB, ng/mL, normal range: ≤7.2 | 65.5(14,123) | 72(25,110) | 56(3116) | 101(15,182) | 0.493 |
 Increased | 46(43%) | 23(46%) | 6(26%) | 6(55%) | / |
 Lactate dehydrogenase, U/L, normal range: 135–214 | 262(228,333) | 261(226,325) §△ | 267(236,340) *△ | 264(225,328) *§ | < 0.001 |
 Troponin, pg/mL, normal range: ≤15.6 | 4.5(1.9,10) | 3.6(1.9,5.9) △ | 6.7(2.6,12.3) ∫ | 5.2(3.4,15.7) *& | 0.013 |
 Myoglobin, ng/mL, normal range: ≤154.9 | 59(41,113) | 49(40,72) | 74(36,127) | 59(24,132) | 0.072 |
 Glucose, mmol/L, normal range: 4.11–6·05 | 6.3 (5.6,8.3) | 6.1(5.4,8.2) | 7.4(5.7,11.7) | 7.9(6.4,9.7) | 0.108 |
Infection-related biomarkers | |||||
 Procalcitonin, ng/mL, normal range: 0.02–0.05 | 0.04 (0.02,0.07) | 0.03(0.02, 0.05) §△ | 0.07(0.04, 0.16) * | 0.07(0.04, 0.19) * | < 0.001 |
 Increased | 33(31%) | 8(16%) | 13(57%) | 7(64%) | / |
 ESR, s, normal range: 0–20 | 40(20,66) | 36(18, 54) § | 68(35, 84) * | 58(42, 68) | 0.002 |
 Increased | 76(70%) | 36(72%) | 18(78%) | 9(82%) | / |
 CRP, mg/L, normal range: < 1 | 25(5,59) | 15(4,39) &△ | 77(30,103) ▼ | 35(20,57) * | < 0.001 |
 Increased | 87(81%) | 43(86%) | 18(78%) | 10(91%) | / |
 Serum ferritin, μg/L, normal range: 30–400 | 497 (234,975) | 376(182,709) §△ | 1202(513,1687) * | 1023(534,1509) * | 0.010 |
 IL-1β, pg/mL, normal range: < 5 | 5(5,5) | 5(5,5) | 5(5,5.3) | 5(5,5) | 0.335 |
 IL-2 receptor, U/mL, normal range: 223–710 | 613(398,918) | 607(428,765) | 628(371,1079) | 1316(424,1653) | 0.445 |
 IL-6, pg/mL, normal range: < 7 | 11(3.6,31.9) | 4.5(3.2, 16.2) | 29.3(15.1,60.3) | 11.7(5.5,79.1) | 0.103 |
 IL-8, pg/mL, normal range: < 62 | 12 (7.6,25.8) | 10.3(6.9,26.2) | 14.7(8,24.8) | 9.4(5.4,43.2) | 0.947 |
 IL-10, pg/mL, normal range: < 9.1 | 5(5,5.3) | 5(5,5) | 5.5(5,9.5) | 5(5,10) | 0.188 |
 TNF-α, pg/mL, normal range: < 8.1 | 7.9(5.6,9.4) | 8.4(5.4,9.5) | 7.2(5.6,9.7) | 7.5(5,8.8) | 0.624 |